We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Safety and Efficacy of Beclomethasone Dipropionate in Patients At Least 12 Years Old With Asthma

- Persistent Asthma
- Completed

Study Title: A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

Teva Identifier: BDB-AS-304

ClinicalTrials.gov Identifier: NCT02040779

Study Status: Completed

Trial Condition(s): Persistent Asthma

Interventions: Drug: Beclomethasone dipropionate breath-actuated inhaler | Drug: Placebo breath-actuated inhaler | Drug: albuterol/salbutamol

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender: Female, Male

Age Range: 12 Years and older

Trial Duration: December 26, 2013 - December 24, 2014

Phase: Phase 3

Study Type

Interventional